Proportion of Asymptomatic SARS-CoV-2 Infections Unclear

FRIDAY, May 27, 2022 (HealthDay News) -- Most severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are not asymptomatic and the secondary attack rate is lower for asymptomatic versus symptomatic infections, according to a review published online May 26 in PLOS Medicine.
Diana Buitrago-Garcia, from the University of Bern in Switzerland, and colleagues updated a living systematic literature review to examine the proportion of patients infected with SARS-CoV-2 who do not experience symptoms and the infectiousness of asymptomatic and presymptomatic compared to symptomatic SARS-CoV-2 infection.
The researchers found that based on 130 studies, heterogeneity was so high that the proportion of asymptomatic infections could not be estimated overall (interquartile range [IQR], 14 to 50 percent; prediction interval, 2 to 90 percent); similar results were seen in 84 studies based on screening d-fined populations (IQR, 20 to 65 percent; prediction interval, 4 to 94 percent). The summary proportion asymptomatic was 19 percent in 46 studies based on contact or outbreak investigations (IQR, 15 to 25 percent; prediction interval, 2 to 70 percent). Based on eight studies, the secondary attack rate was 0.32 in contacts of people with asymptomatic infection versus symptomatic infection (prediction interval, 0.11 to 0.95). The proportion of all SARS-CoV-2 transmission from presymptomatic individuals was higher than from asymptomatic individuals in 13 modeling studies fit to data.
"The true proportion of asymptomatic SARS-CoV-2 infection is still not known," a coauthor said in a statement. "People with truly asymptomatic infection are, however, less infectious than those with symptomatic infection."
One author disclosed financial ties to Sefunda.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Anger, the Heavy Burden
No American will ever forget where he or she was on the morning of Sept. 11,...
FDA Panel to Decide on Novavax COVID Vaccine
TUESDAY, June 7, 2022 (HealthDay News) -- A U.S. Food and Drug Administration...
